Asia-Pacific Biopsy Devices Market By Product (Needle-Based Biopsy Instruments, Procedure Trays, Localization Wires and Other Products), Guidance Technique (Ultrasound-Guided Biopsy, Stereotactic-Guided Biopsy, MRI-Guided Biopsy and Other Guidance Techniques), Application (Breast Biopsy, Lung Biopsy, Colorectal Biopsy, Prostate Biopsy and Other Applications), End User (Hospitals, Academic and Research Institutes, Diagnostic and Imaging Centres), Country (Japan, China, India, South Korea, Australia, Singapore, Malaysia, Thailand, Indonesia, Philippines and Rest Of Asia-Pacific) Industry Trends and Forecast to 2028
Market Analysis and Insights of Biopsy Devices Market
Data Bridge Market Research analyses that the Asia-Pacific biopsy devices market will exhibit a CAGR of around 7.50% for the forecast period of 2021-2028. Rising prevalence of cancer, increased focus on research and development proficiencies in regards to medical devices and on the adoption of advanced healthcare technologies, and rising expenditure on the healthcare infrastructure development especially in the developing economies are the major factors attributable to the growth of biopsy devices market.
Biopsy devices are the medical devices that are used to diagnose and eliminate body’s cancer tissues. Different kinds of biopsy are done such as skin biopsy, fine needle aspiration, vacuum biopsy and needle biopsy to diagnose cancer in the body. The tissue collected it studied under microscope to draw the conclusions.
Upsurge in the demand for minimally invasive treatment globally is one of the major factors fostering the growth of the market. Rising focus on the healthcare technological advancements in the field of biopsy devices coupled with rising initiatives undertaken by government to spread awareness is another market growth determinant. Rising number of hospitals and diagnostic centres and surging inclination towards effective and permanent surgical solutions will further generate lucrative market growth opportunities.
However, high costs associated with the biopsy devices will derail the market growth rate. Lack of medical experts especially in the developing and underdeveloped economies and stringent regulations imposed by the government will further pose challenges for the market. Also, risk of infections will also hamper the market growth rate.
This Asia-Pacific biopsy devices market report provides details of new recent developments, trade regulations, import export analysis, production analysis, value chain optimization, market share, impact of domestic and localised market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on Asia-Pacific biopsy devices market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.
Asia-Pacific Biopsy Devices Market Scope and Market Size
The Asia-Pacific biopsy devices market is segmented on the basis of product, guidance technique, application, and end-user. The growth amongst these segments will help you analyse meagre growth segments in the industries, and provide the users with valuable market overview and market insights to help them in making strategic decisions for identification of core market applications.
- On the basis of product, the biopsy devices market is segmented into needle-based biopsy instruments, procedure trays, localization wires, and other products. Needle-based biopsy instruments are further segmented into core biopsy devices, aspiration biopsy needles, vacuum-assisted biopsy devices, localization wires, procedure trays, and others. Core biopsy devices are further sub-segmented into core biopsy guns and core biopsy needles. Vacuum-assisted biopsy devices are further sub-segmented into vacuum-assisted biopsy systems and vacuum-assisted biopsy needles.
- On the basis of guidance technique, the biopsy devices market is segmented into ultrasound-guided biopsy, stereotactic-guided biopsy, MRI-guided biopsy, and other guidance techniques.
- On the basis of application, the biopsy devices market is segmented into breast biopsy, lung biopsy, colorectal biopsy, prostate biopsy, and other applications.
- On the basis of end user, the biopsy devices market is segmented into hospitals, academic and research institutes, and diagnostic and imaging centers.
Asia-Pacific Biopsy Devices Market Country Level Analysis
The Asia-Pacific biopsy devices market is analysed and market size insights and trends are provided by country, product, guidance technique, application, and end-user as referenced above.
The countries covered in the biopsy devices market report are Japan, China, India, South Korea, Australia, Singapore, Malaysia, Thailand, Indonesia, Philippines and Rest of Asia-Pacific.
The country section of the Asia-Pacific biopsy devices market report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points such as consumption volumes, production sites and volumes, import export analysis, price trend analysis, cost of raw materials, down-stream and upstream value chain analysis are some of the major pointers used to forecast the market scenario for individual countries. Also, presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.
Healthcare infrastructure growth installed base and new technology penetration
The Asia-Pacific biopsy devices market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment, installed base of different kind of products for Asia-Pacific biopsy devices market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on the Asia-Pacific biopsy devices market. The data is available for historic period 2010 to 2019.
Competitive Landscape and Biopsy Devices Market Share Analysis
The Asia-Pacific biopsy devices market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies’ focus related to Asia-Pacific biopsy devices market.
The major players covered in the Asia-Pacific biopsy devices market report are BD, Devicor Medical Products, Inc., ARGON MEDICAL., SOMATEX Medical Technologies GmbH, , Scion Medical Technologies, LLC, STERYLAB S.r.l., EndoMed Systems Alle Rechte vorbehalten, TSK Laboratory Asia Pacific B.V., B. Braun Melsungen AG, Cardinal Health, Siemens, GENERAL ELECTRIC COMPANY, Boston Scientific Corporation, FUJIFILM Holdings Corporation, Olympus Corporation, Medtronic, SRL Diagnostics among other domestic and global players. Market share data is available for Global, North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South America separately. DBMR analysts understand competitive strengths and provide competitive analysis for each competitor separately.
SKU-